{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:32:38Z","timestamp":1788327158983,"version":"build-2803163510"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012325","name":"National Office for Philosophy and Social Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Irritable bowel syndrome (IBS) reduces patients\u2019 quality of life and causes great burdens due to its unclear pathogenesis and criteria for diagnosis. This study aimed to explore the differences in prevalence and the influencing factors for IBS and its subtypes.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The UK Biobank surveyed 174,771 adult participants who completed the Digestive Health Questionnaire (DHQ) through emails and websites. DHQ included the Rome III criteria, IBS symptom severity score, and Patient Health Questionnaire 12 Somatic Symptom score. The UK Biobank also asked regarding previous IBS diagnosis, diagnosis for post-infectious IBS (PI-IBS), and environmental exposures and associated conditions (including anxiety or depression, based on treatment sought or offered). Pearson\u2019s Chi-squared test or Wilcoxon\u2019s rank-sum test was used for potential associations. Binary logic regression based on sex stratification was used to examine associations between selected factors and IBS and its subtypes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> This study included 31,918 participants who met the Rome III criteria for IBS. The pooled prevalence of IBS in the UK Biobank was 18.3%, with mixed IBS as the predominant subtype (59.0%), followed by diarrhea-predominant IBS (25.1%), constipation-predominant IBS (14.7%), and untyped IBS (1.1%). IBS was significantly associated with somatization (male: OR = 5.326, 95% CI = 4.863\u20135.832; female: OR = 4.738, 95% CI = 4.498\u20134.992) and coeliac disease (male: OR = 4.107, 95% CI = 3.132\u20135.385; female: OR = 3.783, 95% CI = 3.310\u20134.323). Differences in antibiotics and mental status were presented among subtypes and sex. Furthermore, 1,787 individuals were diagnosed with PI-IBS in the group of patients with IBS. The prevalence of PI-IBS in IBS was 16.6% in the UK Biobank, and it was characterized by diarrhea, fever, bloody diarrhea, and vomiting.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Somatization and coeliac disease are primary risk factors for IBS. Distinguishing differential risk factors is critical for the precise diagnosis and treatment of IBS subtypes, particularly sex-specific differences in mental health status. General practitioners should focus on the treatment according to IBS subtypes.<\/jats:p>","DOI":"10.3389\/fphar.2022.905564","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T06:17:39Z","timestamp":1661494659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank"],"prefix":"10.3389","volume":"13","author":[{"given":"Kexin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/gut.2003.037697","article-title":"Food elimination based on IgG antibodies in irritable bowel syndrome: A randomised controlled trial","volume":"53","author":"Atkinson","year":"2004","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s2468-1253(20)30212-0","article-title":"The overlap between irritable bowel syndrome and organic gastrointestinal diseases","volume":"6","author":"Aziz","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","article-title":"How the change in IBS criteria from Rome III to Rome IV impacts on clinical characteristics and key pathophysiological factors","volume":"113","author":"Aziz","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3109\/00365521.2012.706828","article-title":"Hematological manifestations of celiac disease","volume":"47","author":"Baydoun","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","article-title":"The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice","volume":"141","author":"Bercik","year":"2011","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.cgh.2020.07.033","article-title":"Characteristics and risk factors of post-infection irritable bowel syndrome after Campylobacter enteritis","volume":"23","author":"Berumen","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13872","DOI":"10.1111\/nmo.13872","article-title":"Anxiety-related factors associated with symptom severity in irritable bowel syndrome","volume":"32","author":"Black","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ajg.2013.105","article-title":"Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life","volume":"108","author":"B\u00f6hn","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1053\/j.gastro.2018.03.064","article-title":"Female-specific association between variants on chromosome 9 and self-reported diagnosis of irritable bowel syndrome","volume":"155","author":"Bonfiglio","year":"2018","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.3390\/jcm6110101","article-title":"Pharmacotherapy for irritable bowel syndrome","volume":"27","author":"Camilleri","year":"2017","journal-title":"J. Clin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/apt.12938","article-title":"Review article: The economic impact of the irritable bowel syndrome","volume":"40","author":"Canavan","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/clep.S40245","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"","journal-title":"Clin. Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1177\/2050640618779923","article-title":"Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey","volume":"6","author":"Card","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","article-title":"What makes UK Biobank special?","volume":"379","author":"Collins","year":"2012","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640612474446","article-title":"A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation","volume":"1","author":"Corsetti","year":"2013","journal-title":"United Eur. Gastroenterol. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gtc.2005.02.008","article-title":"Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors","volume":"34","author":"Cremonini","year":"2005","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: Disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/bf01303162","article-title":"U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig. Dis. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.14309\/ctg.0000000000000012","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: A systematic review","volume":"10","author":"Duan","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","article-title":"Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome","volume":"98","author":"Dunlop","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.gtc.2010.12.012","article-title":"Food: The forgotten factor in the irritable bowel syndrome","volume":"40","author":"Eswaran","year":"2011","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/meg.0b013e32832b9c53","article-title":"Sex differences in dietary coping with gastrointestinal symptoms","volume":"22","author":"Faresj\u00f6","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fphar.2012.00127","article-title":"Brain-gut interactions in IBS","volume":"3","author":"Fichna","year":"2012","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","article-title":"Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis","volume":"264","author":"Fond","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archinternmed.2009.22","article-title":"Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: Systematic review and meta-analysis","volume":"169","author":"Ford","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"151085","DOI":"10.1155\/2012\/151085","article-title":"The gut microbiota and irritable bowel syndrome: Friend or foe?","volume":"2012","author":"Ghoshal","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1136\/gut.52.11.1616","article-title":"Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome","volume":"52","author":"Guthrie","year":"2003","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2982.2007.00997.x","article-title":"Hypersensitivity for capsaicin in patients with functional dyspepsia","volume":"20","author":"Hammer","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/03036758.2019.1695635","article-title":"Irritable bowel syndrome and the gut microbiota [Review]","volume":"50","author":"Heenan","year":"2020","journal-title":"J. R. Soc. N. Z."},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12876-020-01593-5","article-title":"The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: A network meta-analysis","volume":"21","author":"Hu","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: An updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5056\/jnm18028","article-title":"Psychosocial factors associated with irritable bowel syndrome development in Chinese College freshmen","volume":"25","author":"Jiang","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14105","DOI":"10.3748\/wjg.v20.i39.14105","article-title":"Irritable bowel syndrome: A microbiome-gut-brain axis disorder?","volume":"20","author":"Kennedy","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1046\/j.1365-2168.2000.01596.x","article-title":"Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population","volume":"87","author":"Kennedy","year":"2000","journal-title":"Br. J. Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/prbm.S120817","article-title":"Cognitive behavioral therapy for patients with irritable bowel syndrome: Current insights","volume":"10","author":"Kinsinger","year":"2017","journal-title":"Psychol. Res. Behav. Manag."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","article-title":"Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: A systematic review and meta-analysis","volume":"152","author":"Klem","year":"2017","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/00365521.2018.1500638","article-title":"Antibiotics: A risk factor for irritable bowel syndrome in a population-based cohort","volume":"53","author":"Krogsgaard","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1572-0241.2002.05428.x","article-title":"Antibiotics increase functional abdominal symptoms","volume":"97","author":"Maxwell","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)","volume":"29","author":"McKenzie","year":"2016","journal-title":"J. Hum. Nutr. Diet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.gastro.2005.04.012","article-title":"Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: One-year follow-up cohort study","volume":"129","author":"Mearin","year":"2005","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.14309\/ajg.0000000000001038","article-title":"Cumulative effect of psychological alterations on gastrointestinal symptom severity in irritable bowel syndrome","volume":"116","author":"Midenfjord","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"B47","volume-title":"Clinical guidelines. Irritable bowel syndrome in adults: Diagnosis and management","year":"2018"},{"key":"B48","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s2468-1253(20)30217-x","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: A systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/apt.13074","article-title":"Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating","volume":"41","author":"Patel","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gut.2007.140806","article-title":"Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: Involvement of soluble mediators","volume":"58","author":"Piche","year":"2009","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B52","first-page":"e13483","article-title":"Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study","volume-title":"Neurogastroenterol. Motil.","author":"Polster","year":"2018"},{"key":"B53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.genhosppsych.2020.03.004","article-title":"Distinct associations of DSM-5 somatic symptom disorder, the diagnostic criteria for psychosomatic ResearchRevised (DCPR-R) and symptom severity in patients with irritable bowel syndrome [article]","volume":"64","author":"Porcelli","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"G529","DOI":"10.1152\/ajpgi.00207.2012","article-title":"Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome","volume":"305","author":"Ringel","year":"2013","journal-title":"Am. J. physiology Gastrointest. liver physiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0181764","DOI":"10.1371\/journal.pone.0181764","article-title":"Self-help guidebook improved quality of life for patients with irritable bowel syndrome","volume":"12","author":"Schneider","year":"2017","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1055\/s-0031-1281581","article-title":"Post-infectious irritable bowel syndrome--a review of the literature","volume":"49","author":"Schwille-Kiuntke","year":"2011","journal-title":"Z. Gastroenterol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0022-3999(92)90037-3","article-title":"The psychological treatment of patients with functional somatic symptoms: A practical guide","volume":"36","author":"Sharpe","year":"1992","journal-title":"J. Psychosom. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/gut.48.1.20","article-title":"An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome","volume":"48","author":"Simr\u00e9n","year":"2001","journal-title":"Gut"},{"key":"B59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1053\/j.gastro.2009.02.074","article-title":"Postinfectious irritable bowel syndrome","volume":"136","author":"Spiller","year":"2009","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2036.2010.04402.x","article-title":"The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease","volume":"32","author":"Spiller","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3945\/jn.112.159285","article-title":"Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"142","author":"Staudacher","year":"2012","journal-title":"J. Nutr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12876-019-0985-1","article-title":"Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries","volume":"19","author":"Tack","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.12.023","article-title":"The brain-gut-microbiotal Axis: A framework for understanding functional gi illness and their therapeutic interventions","volume":"84","author":"Tait","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/oxfordjournals.aje.a117548","article-title":"Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization","volume":"142","author":"Talley","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"B66","first-page":"678","article-title":"Treatment of functional gi disorders with psychotropic medicines: A review of evidence with a practical approach","volume":"2","author":"Thiwan","year":"2006","journal-title":"Gastroenterol. Hepatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5056\/jnm16069","article-title":"Dietary triggers in irritable bowel syndrome: Is there a role for gluten?","volume":"22","author":"Volta","year":"2016","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/gast.2002.32392","article-title":"Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/gut.27.1.37","article-title":"Non-colonic features of irritable bowel syndrome","volume":"27","author":"Whorwell","year":"1986","journal-title":"Gut"},{"key":"B71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/egh.10.19","article-title":"Quality of life measures in irritable bowel syndrome","volume":"4","author":"Wong","year":"2010","journal-title":"Expert Rev. Gastroenterol. Hepatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.905564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T06:17:46Z","timestamp":1661494666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.905564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":71,"alternative-id":["10.3389\/fphar.2022.905564"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.905564","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"article-number":"905564"}}